Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Quentin30on Oct 24, 2023 8:28am
93 Views
Post# 35697803

RE:RE:RE:RE:RE:RE:RE:Not one, but two positive news items out today

RE:RE:RE:RE:RE:RE:RE:Not one, but two positive news items out today actively cheering..?? nope
cowardly shill ?? By cowardly do you mean insulting anyone with a different opinion than my own, if so then yeah, I'm exactly like you.
Briging the company down ? They don't need me to do that, Matt opening his mouth is enough for that to happen (what does the PPS tell you, what does the lack of instutional ownership tell you, what does the complete lack of movement from AN tell you, what does a lack of insider investment tell you..?

 I first invested in this company in 2004... It's my money they've been spending as they dilute my holding year after year. I'm warning would be investors to be cautious of the pumpers and their bile. Anybody having invested on the words of Canadafan and/or Noteable is down on their investment, and will have been for at least 3 years

CURE ? ONCY has not cured anyone. Even in mBC Pela only EXTENDS life by around a YEAR.. That is NOT a cure... other companies are working on those, which will make pela redundant.

A company that's trying to save people's lives.? ONCY could have completed a Phase III in mBC by now with its doublet of Pela and Pax, but they chose not to... so THEY are the ones who have let patients die unnecessarily early, had they only been able to find a partner to fund the trial, and they failed spectacularly on that, and failed after 5 years telling investors they would save time by using a CPI. That ws all BS smoke and mirrors from the company.
 
Cheer on their demise ? NOT at all, I have wanted them to succeed for 20 years, and every trial is the same, not enough proof, or is disappeared without comment... no comment about the Phase II with BMS/Celgene... the Phase III head and neck that they wouod quiclly rectify... Open spats with the trial investigators, a phase III for bladder invasive cancer which was stated by the previous CEO as coming out of nowhere... I eventually got half an answer from Michael Moore, the previous encumbent for investor information=, on some of these points, and he agreed the points made could have been seen as misleading... no f^*& sh &T

Far from wanting this to fail Azzak, I want potential investors to see how risky this investment still is, and remove the rainbow fantasy of buyouts for billions... we sit barely above 100 million...  There is a reason for this... the company is failing to execute.. and as for mBC, we are getting left behind.

REMEMBER - the Patents expire in 2028. If they do not have approval by then, this company is bust. The clock is ticking.

Perhaps you might do something unusual and respond to why you think my 'negative' thoughts are wrong... or will you just resort to type and lash out a few sad vile comments...

pathetic.
<< Previous
Bullboard Posts
Next >>